Valuation: BioGaia AB

Market Cap 11.5B 1.14B 1.02B 951M 866M 1.63B 110B 1.65B 4.45B 56.13B 4.3B 4.2B 180B P/E 2026 *
29.9x
P/E 2027 * 23.9x
Enterprise Value 10.84B 1.08B 958M 896M 816M 1.54B 104B 1.56B 4.2B 52.88B 4.05B 3.96B 170B EV / Sales 2026 *
6.51x
EV / Sales 2027 * 5.76x
Free-Float
80.82%
Yield 2026 *
3.61%
Yield 2027 * 3.85%
1 day-0.44%
1 week-2.25%
Current month-2.58%
1 month-0.18%
3 months-7.21%
6 months-3.17%
Current year+6.59%
1 week 112.8
Extreme 112.8
118.3
1 month 105.4
Extreme 105.4
118.3
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 93.2
Extreme 93.2
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 48.7
Extreme 48.7
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
13/2/26 Buy

Director

582 0.0006%
30/12/25 Buy

General Counsel

390 0.0004%
5/12/25 Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-0.35%-2.25%+7.40%+12.75% 1.14B
-0.62%-2.71%+39.30%+114.07% 1,025B
-2.30%-4.44%+39.03%+66.07% 623B
-0.63%-1.96%+6.36%+74.38% 459B
-1.03%-2.82%+59.56%+39.69% 355B
-0.85%-4.22%+21.39%+39.13% 336B
-0.07%-1.90%+12.98%+25.86% 270B
-0.16%-4.56%-3.81%+9.41% 247B
-3.38%+0.30%+36.44%+51.54% 220B
-1.04%-1.46%+32.70%+96.82% 183B
Average -1.05%-1.73%+25.14%+52.97% 371.94B
Weighted average by Cap. -1.08%-2.11%+30.23%+69.33%

Financials

2026 *2027 *
Net sales 1.66B 166M 147M 138M 125M 236M 15.95B 239M 645M 8.12B 622M 609M 26.1B 1.89B 188M 167M 156M 142M 267M 18.07B 271M 730M 9.2B 705M 689M 29.56B
Net income 385M 38.31M 34.03M 31.82M 29M 54.6M 3.69B 55.35M 149M 1.88B 144M 141M 6.03B 480M 47.77M 42.43M 39.68M 36.16M 68.07M 4.6B 69.01M 186M 2.34B 179M 175M 7.52B
Net Debt -666M -66.23M -58.82M -55.01M -50.13M -94.38M -6.38B -95.67M -258M -3.25B -249M -243M -10.43B -648M -64.44M -57.23M -53.52M -48.77M -91.82M -6.2B -93.09M -251M -3.16B -242M -237M -10.15B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
02/10/26 SEK 113.50 -0.18% 9,521
01/10/26 SEK 113.70 -2.15% 99,181
30/09/26 SEK 116.20 +1.40% 182,227
29/09/26 SEK 114.60 +0.44% 134,314
28/09/26 SEK 114.10 -1.47% 282,828
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
113.70SEK
Average target price
155.50SEK
Spread / Average Target
+36.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock